Cellulite Treatment Market By Treatment Procedure, Cellulite And End User- Global Industry Analysis And Forecast To 2023

Published On : June 2018 Pages : 180 Category: Healthcare IT Report Code : HC06877

Industry Outlook and Trend Analysis

The Cellulite Treatment Market has encountered significant development in the recent years and is foreseen to grow tremendously over the forecast period. Cellulite treatment is a quickly developing industry that has denoted its essence with the rising obese populace. The issue is more pervasive in women, because of their body structure and diverse areas where fat or wax effectively gets stored. A quickly growing aged populace; expanding pervasiveness of chronic illnesses, for example, cancer and cardiovascular ailment; developing awareness among patients; and overwhelming interests in clinical advancement are only a portion of the elements that are affecting the development of the market.

Drivers and Restraints

It is seen that individuals are fit for managing the propelled restorative surgeries, as there is accessibility of discretionary income. Developed countries incorporate a greater amount of such individuals who are fit for bearing advanced healthcare services facilities as opposed to the ones in developing economies. Critical rise on the planet’s middle-class population throughout the following couple of years will bring about increment in the buying power and optional spending, which are the key components in charge of the dependability and development of cosmetic procedure market worldwide. One of the major factors hampering the development of cellulite treatment market is the increasing popularity of herbal massage.

Market Segmentation

The Cellulite Treatment Market is segmented on the basis of treatment procedure, cellulite and end user. Based on treatment procedure the market is segmented into non-invasive, minimally invasive and topical treatment out of which non-invasive is a highly lucrative market that leads in terms of market value and growth rate during the forecast period. In terms of cellulite the market is segmented into soft cellulite, hard cellulite and edematous cellulite. Based on end user the market is segmented into hospitals, ambulatory surgical canters and specialized dermatology clinics. Hospitals are the leading segment and are foreseen to develop significantly over the estimate time frame.

Regional Outlook and Trend Analysis

Among the major territorial divisions made for the examination directed on worldwide cellulite treatment market, North America demonstrates the most grounded prospects with a normal market estimation of over US$ 2,100 Mn, developing at a significant CAGR amid the gauge time frame. The development is boosted by North America's moderate economy and healthcare market.

Competitive insights

The major players in the market are Inceler Medikal Co Ltd, Tanceuticals LLC, Syneron Medical Inc, Merz Pharma GmbH & Co KGaA and cymedics GmbH & Co KG. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Cellulite Treatment Market is segmented as follows-

By Treatment Procedure:

  • Minimally Invasive
  • Non-Invasive
  • Topical Treatment

By Cellulite:

  • Hard Cellulite
  • Soft Cellulite
  • Edematous Cellulite               

By End User:

  • Ambulatory Surgical Centres
  • Specialized Dermatology Clinics
  • Hospitals

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2023?
  • What will be the industry market growth from 2015 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Cellulite Treatment Market, By Treatment Procedure, Estimates and Forecast, 2014-2023($Billion)

o    Non-Invasive

o    Minimally Invasive

o    Topical Treatment

·         Cellulite Treatment Market, By Cellulite, Estimates and Forecast, 2014-2023($Billion)

o    Soft Cellulite

o    Hard Cellulite

o    Edematous Cellulite

·         Cellulite Treatment Market, By End User, Estimates and Forecast, 2014-2023($Billion)

o    Hospitals

o    Ambulatory Surgical Centers

o    Specialized Dermatology Clinics

·         Cellulite Treatment Market, By Region, Estimates and Forecast, 2014-2023($Billion)

o    North America

§  North America Cellulite Treatment Market, By Country

o    U.S. Cellulite Treatment Market

o    Canada Cellulite Treatment Market

o    Mexico Cellulite Treatment Market

o    Europe

§  Europe Cellulite Treatment Market, By Country

o    Germany Cellulite Treatment Market

o    UK Cellulite Treatment Market

o    France Cellulite Treatment Market

o    Russia Cellulite Treatment Market

o    Italy Cellulite Treatment Market

o    Rest of Europe Cellulite Treatment Market

o    Asia-Pacific

§  Asia-Pacific Cellulite Treatment Market, By Country

o    China Cellulite Treatment Market

o    Japan Cellulite Treatment Market

o    South Korea Cellulite Treatment Market

o    India Cellulite Treatment Market

o    Southeast Asia Cellulite Treatment Market

o    Rest of Asia-Pacific Cellulite Treatment Market

o    South America

§  South America Cellulite Treatment Market

o    Brazil Cellulite Treatment Market

o    Argentina Cellulite Treatment Market

o    Columbia Cellulite Treatment Market

o    South Africa Cellulite Treatment Market

o    Rest of South America Cellulite Treatment Market

o    Middle East and Africa

§  Middle East and Africa Cellulite Treatment Market

o    Saudi Arabia Cellulite Treatment Market

o    UAE Cellulite Treatment Market

o    Egypt Cellulite Treatment Market

o    Nigeria Cellulite Treatment Market

o    South Africa Cellulite Treatment Market

o    Rest of MEA Cellulite Treatment Market

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2014-2023)

4.1.2.  Canada Market States and Outlook (2014-2023)

4.1.3.  Mexico Market States and Outlook (2014-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2014-2023)

4.2.2.  France Market States and Outlook (2014-2023)

4.2.3.  UK Market States and Outlook (2014-2023)

4.2.4.  Russia Market States and Outlook (2014-2023)

4.2.5.  Italy Market States and Outlook (2014-2023)

4.2.6.  Rest of Europe Market States and Outlook (2014-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2014-2023)

4.3.2.  Japan Market States and Outlook (2014-2023)

4.3.3.  Korea Market States and Outlook (2014-2023)

4.3.4.  India Market States and Outlook (2014-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2014-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2014-2023)

4.4.2.  Argentina Market States and Outlook (2014-2023)

4.4.3.  Columbia Market States and Outlook (2014-2023)

4.4.4.  Rest of South America Market States and Outlook (2014-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2014-2023)

4.5.2.  UAE Market States and Outlook (2014-2023)

4.5.3.  Egypt Market States and Outlook (2014-2023)

4.5.4.  Nigeria Market States and Outlook (2014-2023)

4.5.5.  South Africa Market States and Outlook (2014-2023)

4.5.6.  Rest of MEA Market States and Outlook (2014-2023)

5.       Cellulite Treatment Market, By Treatment Procedure

5.1.       Introduction

5.2.       Global Cellulite Treatment Sales, Revenue and Market Share by Treatment Procedure (2014-2018)

5.2.1.  Global Cellulite Treatment Sales and Sales Share by Treatment Procedure (2014-2018)

5.2.2.  Global Cellulite Treatment Revenue and Revenue Share by Treatment Procedure (2014-2018)

5.3.       Non-Invasive

5.3.1.  Global Non-Invasive Sales and Growth Rate (2014-2018)

5.4.       Minimally Invasive

5.4.1.  Global Minimally Invasive Sales and Growth Rate (2014-2018)

5.5.       Topical Treatment

5.5.1.  Global Topical Treatment Sales and Growth Rate (2014-2018)

6.       Cellulite Treatment Market, By Cellulite

6.1.       Introduction

6.2.       Global Cellulite Treatment Sales, Revenue and Market Share by Cellulite (2014-2018)

6.2.1.  Global Cellulite Treatment Sales and Sales Share by Cellulite (2014-2018)

6.2.2.  Global Cellulite Treatment Revenue and Revenue Share by Cellulite (2014-2018)

6.3.       Soft Cellulite

6.3.1.  Global Soft Cellulite Sales and Growth Rate (2014-2018)

6.4.       Hard Cellulite

6.4.1.  Global Hard Cellulite Sales and Growth Rate (2014-2018)

6.5.       Edematous Cellulite

6.5.1.  Global Edematous Cellulite Sales and Growth Rate (2014-2018)

7.       Cellulite Treatment Market, By End User

7.1.       Introduction

7.2.       Global Cellulite Treatment Sales, Revenue and Market Share by End User (2014-2018)

7.2.1.  Global Cellulite Treatment Sales and Sales Share by End User (2014-2018)

7.2.2.  Global Cellulite Treatment Revenue and Revenue Share by End User (2014-2018)

7.3.       Hospitals

7.3.1.  Global Hospitals Sales and Growth Rate (2014-2018)

7.4.       Ambulatory Surgical Centers

7.4.1.  Global Ambulatory Surgical Centers Sales and Growth Rate (2014-2018)

7.5.       Specialized Dermatology Clinics

7.5.1.  Global Specialized Dermatology Clinics Sales and Growth Rate (2014-2018)

8.       Cellulite Treatment Market, By Region

8.1.       Introduction

8.2.       Global Cellulite Treatment Sales, Revenue and Market Share by Regions

8.2.1.  Global Cellulite Treatment Sales by Regions (2014-2018)

8.2.2.  Global Cellulite Treatment Revenue by Regions (2014-2018)

8.3.       North America Cellulite Treatment by Countries

8.3.1.  North America Cellulite Treatment Sales and Growth Rate (2014-2018)

8.3.2.  North America Cellulite Treatment Revenue and Growth Rate (2014-2018)

8.3.3.  North America Cellulite Treatment Sales by Countries (2014-2018)

8.3.4.  North America Cellulite Treatment Revenue (Million USD) by Countries (2014-2018)

8.3.5.  U.S.

8.3.5.1.    United States Cellulite Treatment Sales and Growth Rate (2014-2018)

8.3.5.2.    United States Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.3.6.  Canada

8.3.6.1.    Canada Cellulite Treatment Sales and Growth Rate (2014-2018)

8.3.6.2.    Canada Cellulite Treatment Sales (Millions USD) and Growth Rate (2014-2018)

8.3.7.  Mexico

8.3.7.1.    Mexico Cellulite Treatment Sales and Growth Rate (2014-2018)

8.3.7.2.    Mexico Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.       Europe Cellulite Treatment by Countries

8.4.1.  Europe Cellulite Treatment Sales and Growth Rate (2014-2018)

8.4.2.  Europe Cellulite Treatment Revenue and Growth Rate (2014-2018)

8.4.3.  Europe Cellulite Treatment Sales by Countries (2014-2018)

8.4.4.  Europe Cellulite Treatment Revenue (Million USD) by Countries (2014-2018)

8.4.5.  Germany

8.4.5.1.    Germany Cellulite Treatment Sales and Growth Rate (2014-2018)

8.4.5.2.    Germany Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.6.  UK

8.4.6.1.    UK Cellulite Treatment Sales and Growth Rate (2014-2018)

8.4.6.2.    UK Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.7.  France

8.4.7.1.    France Cellulite Treatment Sales and Growth Rate (2014-2018)

8.4.7.2.    France Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.8.  Russia

8.4.8.1.    Russia Cellulite Treatment Sales and Growth Rate (2014-2018)

8.4.8.2.    Russia Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.9.  Italy

8.4.9.1.    Italy Cellulite Treatment Sales and Growth Rate (2014-2018)

8.4.9.2.    Italy Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.4.10.      Rest of Europe

8.4.10.1. Rest of Europe Cellulite Treatment Sales and Growth Rate (2014-2018)

8.4.10.2. Rest of Europe Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.       Asia-Pacific

8.5.1.  Asia-Pacific Cellulite Treatment Sales and Growth Rate (2014-2018)

8.5.2.  Asia-Pacific Cellulite Treatment Revenue and Growth Rate (2014-2018)

8.5.3.  Asia-Pacific Cellulite Treatment Sales by Countries (2014-2018)

8.5.4.  Asia-Pacific Cellulite Treatment Revenue (Million USD) by Countries (2014-2018)

8.5.5.  China

8.5.5.1.    China Cellulite Treatment Sales and Growth Rate (2014-2018)

8.5.5.2.    China Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.6.  Japan

8.5.6.1.    Japan Cellulite Treatment Sales and Growth Rate (2014-2018)

8.5.6.2.    Japan Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.6.3.     

8.5.7.  Korea

8.5.7.1.    Korea Cellulite Treatment Sales and Growth Rate (2014-2018)

8.5.7.2.    Korea Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.8.  India

8.5.8.1.    India Cellulite Treatment Sales and Growth Rate (2014-2018)

8.5.8.2.    India Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.9.  Southeast Asia

8.5.9.1.    Southeast Asia Cellulite Treatment Sales and Growth Rate (2014-2018)

8.5.9.2.    Southeast Asia Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.5.10.      Rest of Asia-Pacific

8.5.10.1. Rest of Asia-Pacific Cellulite Treatment Sales and Growth Rate (2014-2018)

8.5.10.2. Rest of Asia-Pacific Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.       South America

8.6.1.  South America Cellulite Treatment Sales and Growth Rate (2014-2018)

8.6.2.  South America Cellulite Treatment Revenue and Growth Rate (2014-2018)

8.6.3.  South America Cellulite Treatment Sales by Countries (2014-2018)

8.6.4.  South America Cellulite Treatment Revenue (Million USD) by Countries (2014-2018)

8.6.5.  Brazil

8.6.5.1.    Brazil Cellulite Treatment Sales and Growth Rate (2014-2018)

8.6.5.2.    Brazil Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.6.  Argentina

8.6.6.1.    Argentina Cellulite Treatment Sales and Growth Rate (2014-2018)

8.6.6.2.    Argentina Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.7.  Columbia

8.6.7.1.    Columbia Cellulite Treatment Sales and Growth Rate (2014-2018)

8.6.7.2.    Columbia Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.6.8.  Rest of South America

8.6.8.1.    Rest of South America Cellulite Treatment Sales and Growth Rate (2014-2018)

8.6.8.2.    Rest of South America Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.       Middle East and Africa

8.7.1.  Middle East and Africa Cellulite Treatment Sales and Growth Rate (2014-2018)

8.7.2.  Middle East and Africa Cellulite Treatment Revenue and Growth Rate (2014-2018)

8.7.3.  Middle East and Africa Cellulite Treatment Sales by Countries (2014-2018)

8.7.4.  Middle East and Africa Cellulite Treatment Revenue (Million USD) by Countries (2014-2018)

8.7.5.  Saudi Arabia

8.7.5.1.    Saudi Arabia Cellulite Treatment Sales and Growth Rate (2014-2018)

8.7.5.2.    Saudi Arabia Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.6.  United Arab Emirates

8.7.6.1.    United Arab Emirates Cellulite Treatment Sales and Growth Rate (2014-2018)

8.7.6.2.    United Arab Emirates Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.7.  Egypt

8.7.7.1.    Egypt Cellulite Treatment Sales and Growth Rate (2014-2018)

8.7.7.2.    Egypt Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.8.  Nigeria

8.7.8.1.    Nigeria Cellulite Treatment Sales and Growth Rate (2014-2018)

8.7.8.2.    Nigeria Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.9.  South Africa

8.7.9.1.    South Africa Cellulite Treatment Sales and Growth Rate (2014-2018)

8.7.9.2.    South Africa Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

8.7.10.      Rest of Middle East and Africa

8.7.10.1. Rest of Middle East and Africa Cellulite Treatment Sales and Growth Rate (2014-2018)

8.7.10.2. Rest of Middle East and Africa Cellulite Treatment Revenue (Millions USD) and Growth Rate (2014-2018)

9.       Company Profiles

9.1.       Merz Pharma GmbH & Co. KGaA

9.1.1.  Business Overview

9.1.2.  Product Portfolio

9.1.3.  Strategic Developments

9.1.4.  Sales, Revenue and Market Share

9.2.       Intel Corporation

9.2.1.  Business Overview

9.2.2.  Product Portfolio

9.2.3.  Strategic Developments

9.2.4.  Sales, Revenue and Market Share

9.3.       Cynosure, Inc. (Sub. Hologic Inc.)

9.3.1.  Business Overview

9.3.2.  Product Portfolio

9.3.3.  Strategic Developments

9.3.4.  Sales, Revenue and Market Share

9.4.       Tanceuticals, LLC.

9.4.1.  Business Overview

9.4.2.  Product Portfolio

9.4.3.  Strategic Developments

9.4.4.  Sales, Revenue and Market Share

9.5.       Inceler Medikal Co. Ltd.

9.5.1.  Business Overview

9.5.2.  Product Portfolio

9.5.3.  Strategic Developments

9.5.4.  Sales, Revenue and Market Share

9.6.       Cymedics

9.6.1.  Business Overview

9.6.2.  Product Portfolio

9.6.3.  Strategic Developments

9.6.4.  Sales, Revenue and Market Share

9.7.       Nubway

9.7.1.  Business Overview

9.7.2.  Product Portfolio

9.7.3.  Strategic Developments

9.7.4.  Sales, Revenue and Market Share

9.8.       Zimmer Aesthetics

9.8.1.  Business Overview

9.8.2.  Product Portfolio

9.8.3.  Strategic Developments

9.8.4.  Sales, Revenue and Market Share

9.9.       Syneron Medical Inc.

9.9.1.  Business Overview

9.9.2.  Product Portfolio

9.9.3.  Strategic Developments

9.9.4.  Sales, Revenue and Market Share

10.   Global Cellulite Treatment Market Competition, by Manufacturer

10.1.    Global Cellulite Treatment Sales and Market Share by Manufacturer (2016-2017)

10.2.    Global Cellulite Treatment Revenue and Market Share by Manufacturer (2016-2017)

10.3.    Global Cellulite Treatment Price by Manufacturer (2016-2017)

10.4.    Top 5 Cellulite Treatment Manufacturer Market Share

10.5.    Market Competition Trend

11.   Cellulite Treatment Market Forecast (2018-2023)

11.1.    Global Cellulite Treatment Sales, Revenue (Millions USD) and Growth Rate (2018-2023)

11.2.    Cellulite Treatment Market Forecast by Regions (2018-2023)

11.2.1.      North America Cellulite Treatment Market Forecast (2018-2023)

11.2.1.1. United States Cellulite Treatment Market Forecast (2018-2023)

11.2.1.2. Canada Cellulite Treatment Market Forecast (2018-2023)

11.2.1.3. Mexico Cellulite Treatment Market Forecast (2018-2023)

11.2.2.      Europe Cellulite Treatment Market Forecast (2018-2023)

11.2.2.1. Germany Cellulite Treatment Market Forecast (2018-2023)

11.2.2.2. United Kingdom Cellulite Treatments Market Forecast (2018-2023)

11.2.2.3. France Cellulite Treatment Market Forecast (2018-2023)

11.2.2.4. Russia Cellulite Treatment Market Forecast (2018-2023)

11.2.2.5. Italy Cellulite Treatment Market Forecast (2018-2023)

11.2.2.6. Rest of the Europe Cellulite Treatment Market Forecast (2018-2023)

11.2.3.      Asia-Pacific Cellulite Treatment Market Forecast (2018-2023)

11.2.3.1. China Cellulite Treatment Market Forecast (2018-2023)

11.2.3.2. Japan Cellulite Treatment Market Forecast (2018-2023)

11.2.3.3. Korea Cellulite Treatment Market Forecast (2018-2023)

11.2.3.4. India Cellulite Treatment Market Forecast (2018-2023)

11.2.3.5. Southeast Asia Cellulite Treatment Market Forecast (2018-2023)

11.2.3.6. Rest of Asia-Pacific Cellulite Treatment Market Forecast (2018-2023)

11.2.4.      South America Cellulite Treatment Market Forecast (2018-2023)

11.2.4.1. Brazil Cellulite Treatment Market Forecast (2018-2023)

11.2.4.2. Argentina Cellulite Treatment Market Forecast (2018-2023)

11.2.4.3. Columbia Cellulite Treatment Market Forecast (2018-2023)

11.2.4.4. Rest of South America Cellulite Treatment Market Forecast (2018-2023)

11.2.5.      Middle East and Africa Cellulite Treatment Market Forecast (2018-2023)

11.2.5.1. Saudi Arabia Cellulite Treatment Market Forecast (2018-2023)

11.2.5.2. UAE Cellulite Treatment Market Forecast (2018-2023)

11.2.5.3. Egypt Cellulite Treatment Market Forecast (2018-2023)

11.2.5.4. Nigeria Cellulite Treatment Market Forecast (2018-2023)

11.2.5.5. South Africa Cellulite Treatment Market Forecast (2018-2023)

11.2.5.6. Rest of MEA Cellulite Treatment Market Forecast (2018-2023)

11.3.    Cellulite Treatment Market Forecast by Treatment Procedure (2018-2023)

11.3.1.      Global Cellulite Treatment Sales Forecast by Treatment Procedure (2018-2023)

11.3.2.      Global Cellulite Treatment Sales Market Share Forecast by Treatment Procedure (2018-2023)

11.4.    Cellulite Treatment Market Forecast by Cellulite (2018-2023)

11.4.1.      Global Cellulite Treatment Sales Forecast by Cellulite (2018-2023)

11.4.2.      Global Cellulite Treatment Sales Market Share Forecast by Cellulite (2018-2023)

11.5.    Cellulite Treatment Market Forecast by End User (2018-2023)

11.5.1.      Global Cellulite Treatment Sales Forecast by End User (2018-2023)

11.5.2.      Global Cellulite Treatment Sales Market Share Forecast by End User (2018-2023)


List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Cellulite Treatment Market.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*